Evidence map›Paper›PMID 36822808›Full record

ArticleBMJ open2023

Cumulative incidence of SARS-CoV-2 infection within the homeless population: insights from a city-wide longitudinal study.

Emilie Mosnier, Sandrine Loubiere, Elisabetta Monfardini, Agathe Alibert, Jordi Landier, Laeticia Ninoves, Thomas Bosetti, Pascal Auquier, Marine Mosnier, Stephanie Nguengang Wakap and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04408131 (Morbi-mortality by COVID-19 Among Homeless People in Marseille), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04408131 nawithdrawnnot on this map

Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study

TypeinterventionalSponsorAssistance Publique Hopitaux De MarseilleRan2020 to 2023Enrolled0ConditionsHomelessArmsBlood sample
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Health of homeless individuals during the COVID-19 pandemic].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023
    Review
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Emilie MosnierDepartment of Psychiatry, Assistance Publique - Hôpitaux de Marseille, Marseille, France emilie.mosnier@gmail.com.ORCID 0000-0002-6004-3323
Sandrine LoubiereDepartment of Clinical Research and Innovation, Support Unit for clinical research and economic evaluation, Assistance Publique - Hôpitaux de Marseille, Marseille, France.ORCID 0000-0001-6715-1223
Elisabetta MonfardiniDepartment of Clinical Research and Innovation, Support Unit for clinical research and economic evaluation, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
Agathe AlibertDepartment of Clinical Research and Innovation, Support Unit for clinical research and economic evaluation, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
Jordi LandierAix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Laeticia NinovesUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.
Thomas BosettiMédecins du Monde - Doctors of the World, Marseille, France.
Pascal AuquierDepartment of Clinical Research and Innovation, Support Unit for clinical research and economic evaluation, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
Marine MosnierMédecins du Monde - Doctors of the World, Marseille, France.
Stephanie Nguengang WakapMédecins du Monde - Doctors of the World, Paris, France.
Josiane WarszawskiINSERM CESP U1018, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Aurelie TinlandDepartment of Psychiatry, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
Inserm · FRCeres · USInstitut des Mondes Africains · FRAssistance Publique Hôpitaux de Marseille · FRCegep de Saint Hyacinthe · CADoctors of the World · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to determine the risk factors associated with SARS-CoV-2 infection in a cohort of homeless people using survival analysis. Seroprevalence in the homeless community was also compared with that of the general population.

designCohort study.

settingData were collected across two testing sessions, 3 months apart, during which each participant was tested for anti-SARS-CoV-2 antibodies and completed a face-to-face survey.

participantsAll homeless adults sleeping rough, in slums or squats, in emergency shelters or transitional accommodation in Marseille were eligible. PRIMARY OUTCOME MEASURES: Occurrence of a seroconversion event defined as a biologically confirmed SARS-CoV-2 infection. Local data from a national seroprevalence survey were used for comparison between homeless people and the general population.

resultsA total of 1249 people were included. SARS-CoV-2 seroprevalence increased from 6.0% (4.7-7.3) during the first session to 18.9% (16.0-21.7) during the second one, compared with 3.0% (1.9-4.2) and 6.5% (4.5-8.7) in the general population. Factors significantly associated with an increased risk of COVID-19 infection were: having stayed in emergency shelters (1.93 (1.18-3.15)), being an isolated parent (1.64 (1.07-2.52)) and having contact with more than 5-15 people per day (1.84 (1.27-2.67)). By contrast, smoking (0.46 (0.32-0.65)), having financial resources (0.70 (0.51-0.97)) and psychiatric or addictive comorbidities (0.52 (0.32-0.85)) were associated with a lower risk.

conclusionWe confirm that homeless people have higher infection rates than the general population, with increased risk in emergency shelters. There is growing evidence that, in addition to usual preventive measures, public policies should pay attention to adapt the type of accommodation and overall approach of precariousness. TRIAL REGISTRATION NUMBER: NCT04408131.

Indexed as

COVID-19AdultCohort StudiesHumansIncidenceLongitudinal StudiesSARS-CoV-2Seroepidemiologic StudiesCOVID-19EPIDEMIOLOGYPublic health

Identifiers

PMID36822808
PMCPMC9950589
OpenAlexW4321639053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.